| 1 | [SID51089742] | Active | IC50 | 9.69 | Dose response confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay [AID651693, Type: confirmatory] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | IC50 | 9.69 [uM] | | BioAssay | Dose response confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay | | AID | 651693 | | BioAssay type | confirmatory | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 2 | [SID51089742] | Active | IC50 | 19.3 | Dose response confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a kinetic FRET assay [AID651697, Type: confirmatory] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | IC50 | 19.3 [uM] | | BioAssay | Dose response confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a kinetic FRET assay | | AID | 651697 | | BioAssay type | confirmatory | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 3 | [SID51089742] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 4 | [SID51089742] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 5 | [SID51089742] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 6 | [SID51089742] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 7 | [SID51089742] | Active | | | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists [AID485344, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists | | AID | 485344 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 8 | [SID51089742] | Active | | | Fluorescence-based biochemical high throughput confirmation assay to identify inhibitors of Protein Phosphatase 1 (PP1) [AID2358, Type: screening] | PPP1CA gene product [Homo sapiens] [gi:56790945] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay to identify inhibitors of Protein Phosphatase 1 (PP1) | | AID | 2358 | | BioAssay type | screening | | Target | PPP1CA gene product [Homo sapiens] [gi:56790945] | | PubMed | | | Data Table |  |
|
| 9 | [SID51089742] | Active | | | Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1). [AID2235, Type: screening] | PPP1CA gene product [Homo sapiens] [gi:56790945] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1). | | AID | 2235 | | BioAssay type | screening | | Target | PPP1CA gene product [Homo sapiens] [gi:56790945] | | PubMed | | | Data Table |  |
|
| 10 | [SID51089742] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 11 | [SID51089742] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 12 | [SID51089742] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 13 | [SID51089742] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 14 | [SID51089742] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 15 | [SID51089742] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 16 | [SID51089742] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 17 | [SID51089742] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 18 | [SID51089742] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 19 | [SID51089742] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 20 | [SID51089742] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). [AID2149, Type: screening] | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). | | AID | 2149 | | BioAssay type | screening | | Target | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] | | PubMed | | | Data Table |  |
|
| 21 | [SID51089742] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). [AID1962, Type: screening] | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). | | AID | 1962 | | BioAssay type | screening | | Target | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] | | PubMed | | | Data Table |  |
|
| 22 | [SID51089742] | Active | | | Single concentration confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay [AID651678, Type: screening] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | Single concentration confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay | | AID | 651678 | | BioAssay type | screening | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 23 | [SID51089742] | Active | | | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay [AID624204, Type: screening] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay | | AID | 624204 | | BioAssay type | screening | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 24 | [SID51089742] | Active | | | Single concentration confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a kinetic FRET assay [AID651690, Type: screening] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | Single concentration confirmation of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a kinetic FRET assay | | AID | 651690 | | BioAssay type | screening | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 25 | [SID51089742] | Active | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] | | PubMed | | | Data Table |  |
|
| 26 | [SID51089742] | Active | | | Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1. [AID2153, Type: screening] | unnamed protein product [Aspergillus oryzae] [gi:83774548] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1. | | AID | 2153 | | BioAssay type | screening | | Target | unnamed protein product [Aspergillus oryzae] [gi:83774548] | | PubMed | | | Data Table |  |
|
| 27 | [SID51089742] | Active | | | Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1. [AID2153, Type: screening] | unnamed protein product [Aspergillus oryzae] [gi:83774548] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen assay for inhibitors of tRNA 2'-phosphotransferase (TPT1): biochemical high throughput screening assay to identify inhibitors of RNAse T1. | | AID | 2153 | | BioAssay type | screening | | Target | unnamed protein product [Aspergillus oryzae] [gi:83774548] | | PubMed | | | Data Table |  |
|
| 28 | [SID51089742] | Active | | | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay [AID651999, Type: screening] | COPS5 gene product [Homo sapiens] [gi:38027923] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay | | AID | 651999 | | BioAssay type | screening | | Target | COPS5 gene product [Homo sapiens] [gi:38027923] | | PubMed | | | Data Table |  |
|
| 29 | [SID51089742] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 30 | [SID51089742] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 31 | [SID51089742] | Inactive | Potency | 19.9526 | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction [AID624246, Type: confirmatory] | ERG gene product [Homo sapiens] [gi:343478176] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction | | AID | 624246 | | BioAssay type | confirmatory | | Target | ERG gene product [Homo sapiens] [gi:343478176] | | PubMed | | | Data Table |  |
|
| 32 | [SID51089742] | Inactive | Potency | 19.9526 | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction [AID624246, Type: confirmatory] | ERG gene product [Homo sapiens] [gi:343478176] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction | | AID | 624246 | | BioAssay type | confirmatory | | Target | ERG gene product [Homo sapiens] [gi:343478176] | | PubMed | | | Data Table |  |
|
| 33 | [SID51089742] | Inactive | Potency | 50.1187 | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | Potency | 50.1187 [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 34 | [SID51089742] | Inactive | Potency | | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624288, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624288 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 35 | [SID51089742] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 36 | [SID51089742] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 37 | [SID51089742] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 38 | [SID51089742] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 39 | [SID51089742] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 40 | [SID51089742] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 41 | [SID51089742] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 42 | [SID51089742] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 43 | [SID51089742] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 44 | [SID51089742] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 45 | [SID51089742] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 46 | [SID51089742] | Inactive | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 47 | [SID51089742] | Inactive | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 48 | [SID51089742] | Inactive | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 49 | [SID51089742] | Inactive | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 50 | [SID51089742] | Inactive | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 51089742 | | CID | 56642851 | | Outcome | Inactive | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|